HEFFTER BLOG

The recent survey of difficult recreational psilocybin experiences by Heffter Board member and researcher Roland Griffiths, Ph.D. and his team at Johns Hopkins University draws two main conclusions that at first may seem contradictory. On one hand, psilocybin use outside the medical setting occasionally involves traumatic and potentially harmful experiences, as well as occasionally dangerous behaviors. On the other hand, most people report improvements in their quality of life after these difficult experiences.

The medical research setting provides crucial protections from harm that the recreational setting does not: a psychiatric evaluation to exclude subjects with a history of a serious mental disorder that could recur with psilocybin. Another key protection is the presence of specially trained psychotherapists with experience administering psilocybin to support subjects through distressing and confusing experiences, which can happen to anyone in any setting. Finally, the medical research setting provides hours of both pre-session preparation and post-session integration psychotherapy sessions to help the subject maximize the benefit from the session and ensure the positive impacts are enduring.

Please join Heffter Research Institute President and co-founder David Nichols for his presentation “Nearly Half a Century Studying Psychedelics,” an overview of his pioneering career in the field of psychedelic research. Dr. Nichols will appear at 7:00 PM on Saturday, April 30th, at the California Institute...

A team of researchers at Imperial College London produced the first images of the human brain under the influence of LSD. According to ScienceDaily, 20 healthy volunteers received 75 micrograms of LSD. The research team, led by Dr. Robin Carhart-Harris, used advanced imaging technology to study...

A recent article in OUPblog, the online source for news and commentary from the Oxford University Press, covers changing attitudes towards psychedelics. In “Finding a New Perspective on Psychedelics,” editor Matt Turney notes that “The reputation of these compounds is undergoing rehabilitation, but we can’t...

A feature article in the December 2015 issue of Monitor on Psychology, a publication of the American Psychological Association, surveys recent developments in psychedelic science with an emphasis on Heffter-sponsored research. In “One Hit Wonder,” writer Kirsten Weir quotes Heffter researchers Roland Griffiths, Anthony Bossis, and Jeffrey Guss....